Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Impact of the social context on the prognosis of Chagas disease patients: Multilevel analysis of a Brazilian cohort.

Tytuł:
Impact of the social context on the prognosis of Chagas disease patients: Multilevel analysis of a Brazilian cohort.
Autorzy:
Ferreira AM; Graduate Program in Health Sciences, State University of Montes Claros, Montes Claros, Minas Gerais, Brazil.
Sabino ÉC; Institute of Tropical Medicine, University of São Paulo, São Paulo, Brazil.
Oliveira LC; Institute of Tropical Medicine, University of São Paulo, São Paulo, Brazil.
Oliveira CDL; Federal University of São João del-Rey, Research Group in Epidemiology and New Technologies in Health-Centro Oeste Campus, Brazil.
Cardoso CS; Federal University of São João del-Rey, Research Group in Epidemiology and New Technologies in Health-Centro Oeste Campus, Brazil.
Ribeiro ALP; Department of Internal Medicine, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Damasceno RF; Graduate Program in Health Sciences, State University of Montes Claros, Montes Claros, Minas Gerais, Brazil.
Nunes MDCP; Department of Internal Medicine, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Haikal DSA; Graduate Program in Health Sciences, State University of Montes Claros, Montes Claros, Minas Gerais, Brazil.
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2020 Jun 29; Vol. 14 (6), pp. e0008399. Date of Electronic Publication: 2020 Jun 29 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
Język:
English
Imprint Name(s):
Original Publication: San Francisco, CA : Public Library of Science
MeSH Terms:
Chagas Disease*/epidemiology
Social Environment*
Aged ; Brazil/epidemiology ; Cohort Studies ; Female ; Humans ; Logistic Models ; Male ; Middle Aged ; Multilevel Analysis ; Prognosis ; Rural Population
References:
Eur J Heart Fail. 2008 Sep;10(9):824-39. (PMID: 18760965)
Circulation. 1995 Oct 1;92(7):2003-5. (PMID: 7671385)
Circulation. 2013 Mar 12;127(10):1105-15. (PMID: 23393012)
Parasit Vectors. 2016 Jan 27;9:42. (PMID: 26813568)
Int J Parasitol. 2019 Mar;49(3-4):301-310. (PMID: 30738925)
Nat Rev Cardiol. 2012 Oct;9(10):576-89. (PMID: 22847166)
Cad Saude Publica. 2014 Oct;30(10):2081-91. (PMID: 25388311)
Circulation. 2018 Mar 20;137(12):e67-e492. (PMID: 29386200)
J Epidemiol Community Health. 2004 May;58(5):374-80. (PMID: 15082734)
PLoS Negl Trop Dis. 2017 May 18;11(5):e0005542. (PMID: 28545053)
Eur J Heart Fail. 2009 Jul;11(7):676-83. (PMID: 19553398)
Heart. 2018 Sep;104(18):1522-1528. (PMID: 29523589)
Arq Bras Cardiol. 2005 Apr;84(4):309-13. (PMID: 15880204)
J Am Coll Cardiol. 2013 Aug 27;62(9):767-76. (PMID: 23770163)
Bull World Health Organ. 2012 May 1;90(5):373-8. (PMID: 22589571)
Int J Cardiol. 2008 May 23;126(2):276-8. (PMID: 17467084)
BMJ Open. 2016 May 04;6(5):e011181. (PMID: 27147390)
Rev Esp Cardiol. 2010 Jul;63(7):788-97. (PMID: 20609312)
BMJ. 1996 Apr 20;312(7037):1004-7. (PMID: 8616345)
Rev Bras Epidemiol. 2011 Sep;14 Suppl 1:5-15. (PMID: 22002138)
J Cardiovasc Electrophysiol. 2008 May;19(5):502-9. (PMID: 18266670)
Epidemiol Serv Saude. 2016 Jun;25(spe):7-86. (PMID: 27869914)
Int J Cardiol. 2005 Jul 10;102(2):239-47. (PMID: 15982491)
Ann Epidemiol. 2000 May;10(4):224-38. (PMID: 10854957)
Wkly Epidemiol Rec. 2015 Feb 6;90(6):33-43. (PMID: 25671846)
J Health Care Poor Underserved. 1992 Fall;3(2):321-35. (PMID: 1420668)
Popul Stud (Camb). 2007 Nov;61(3):287-98. (PMID: 17979003)
Arq Bras Cardiol. 2016 Nov;107(5):392-402. (PMID: 27982266)
Lancet. 2003 Jul 19;362(9379):233-41. (PMID: 12885488)
Am J Epidemiol. 2010 Jul 15;172(2):190-6. (PMID: 20581155)
PLoS Negl Trop Dis. 2018 Nov 1;12(11):e0006814. (PMID: 30383777)
Arq Bras Cardiol. 2003 Nov;81 Suppl 6:3-24. (PMID: 15108640)
Br J Gen Pract. 2001 Apr;51(465):303-9. (PMID: 11458485)
PLoS One. 2016 Nov 17;11(11):e0165950. (PMID: 27855177)
Eur Heart J. 2012 Nov;33(21):2719-47. (PMID: 22922413)
Circulation. 2018 Sep 18;138(12):e169-e209. (PMID: 30354432)
J Am Heart Assoc. 2014 Feb 07;3(1):e000632. (PMID: 24510116)
N Engl J Med. 2015 Oct;373(14):1295-306. (PMID: 26323937)
Rev Saude Publica. 2013 Jun;47 Suppl 2:79-86. (PMID: 24346724)
Grant Information:
P50 AI098461 United States AI NIAID NIH HHS; U19 AI098461 United States AI NIAID NIH HHS
Entry Date(s):
Date Created: 20200630 Date Completed: 20200814 Latest Revision: 20240330
Update Code:
20240330
PubMed Central ID:
PMC7351237
DOI:
10.1371/journal.pntd.0008399
PMID:
32598390
Czasopismo naukowe
The present study aims to investigate how the social context contributes to the prognosis of Chagas disease (CD). This is a multilevel study that considered individual and contextual data. Individual data came from a Brazilian cohort study that followed 1,637 patients who lived in 21 municipalities to which CD is endemic, over two years. Contextual data were collected from official Brazilian government databases. The dependent variable was the occurrence of cardiovascular events in CD during the two-year follow-up, defined from the grouping of three possible combined events: death, development of atrial fibrillation, or pacemaker implantation. Analysis was performed using multilevel binary logistic regression. Among the individuals evaluated, 205 (12.5%) manifested cardiovascular events in CD during two years of follow-up. Individuals living in municipalities with a larger rural population had protection for these events (OR = 0.5; 95% CI = 0.4-0.7), while those residing in municipalities with fewer physicians per thousand inhabitants (OR = 1.6; 95% CI = 1.2-2.5) and those living in municipalities with lower Primary Health Care (PHC) coverage (OR = 1.4; 95% CI = 1.1-2.1) had higher chances of experiencing cardiovascular events. Among the individual variables, the probability of experiencing cardiovascular events was higher for individuals aged over 60 years (OR = 1.4; 95% CI = 1.01-2.2), with no stable relationship (OR = 1.4; 95% CI = 0.98-2.1), without previous treatment with Benznidazole (OR = 1.5; 95% CI = 0.98-2.9), with functional class limitation (OR = 2.0; 95% CI = 1.4-2.9), with a QRS complex duration longer than 120 ms (OR = 1.5; 95% CI = 1.1-2.3), and in individuals with high NT-proBNP levels (OR = 6.4; 95% CI = 4.3-9.6). CONCLUSION: The present study showed that the occurrence of cardiovascular events in individuals with CD is determined by individual conditions that express the severity of cardiovascular involvement. However, these individual characteristics are not isolated protagonists of this outcome, and the context in which individuals live, are also determining factors for a worse clinical prognosis.
Competing Interests: The authors have declared that no competing interests exist.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies